Dr. Jane L Meisel
Claim this profileWinship Cancer Institute / Emory University School of Medicine
Area of expertise
Breast Cancer
Jane L Meisel has run 11 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Jane L Meisel has run 5 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Winship Cancer Institute / Emory University School Of Medicine
Emory University Hospital Midtown
Clinical Trials Jane L Meisel is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting
2 awards
Phase 3
12 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
This phase III trial compares the effect of continuation of treatment with pembrolizumab (usual approach) to observation only at preventing cancer from coming back in patients with early-stage triple-negative breast cancer (TNBC) who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. The usual approach for patients with early-stage TNBC who receive preoperative chemotherapy plus pembrolizumab is to continue to receive pembrolizumab for up to 27 weeks after surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation is as good as receiving pembrolizumab for 27 weeks after surgery in triple-negative breast cancer patients who achieved a pathologic complete response after preoperative treatment with chemotherapy and pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
More about Jane L Meisel
Clinical Trial Related
3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jane L Meisel has experience with
- Pembrolizumab
- Tucatinib
- Trastuzumab
- Pertuzumab
- Fulvestrant
- Web Based App Intervention
Breakdown of trials Jane L Meisel has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jane L Meisel specialize in?
Jane L Meisel focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jane L Meisel currently recruiting for clinical trials?
Yes, Jane L Meisel is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Jane L Meisel has studied deeply?
Yes, Jane L Meisel has studied treatments such as Pembrolizumab, Tucatinib, Trastuzumab.
What is the best way to schedule an appointment with Jane L Meisel?
Apply for one of the trials that Jane L Meisel is conducting.
What is the office address of Jane L Meisel?
The office of Jane L Meisel is located at: Winship Cancer Institute / Emory University School of Medicine, Atlanta, Georgia 30322 United States. This is the address for their practice at the Winship Cancer Institute / Emory University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.